Animal study · mice

Vesugen (KED) prevented dendritic spine loss in Alzheimer's mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

This adds early mouse evidence that Vesugen may help protect nerve connections in an Alzheimer's model, but it does not show any benefit in humans.

Kind
Animal study
Studied in
Mice
Published
2021
Journal
Pharmaceuticals (Basel)

What they tested

The team tested whether the KED and EDR peptides protect nerve connections in a mouse model of Alzheimer's disease, and looked for possible molecular reasons.

How the study was done

A study in 5xFAD mice, an Alzheimer's disease mouse model, given daily KED peptide injections into the belly cavity from 2 to 4 months of age at 400 μg/kg. The team also used computer molecular modeling and docking to see how the peptides might bind DNA.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking vesugen? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In 5xFAD mice, daily KED at 400 μg/kg tended to increase neuroplasticity, the brain's ability to change its connections. Both KED and EDR prevented the loss of dendritic spines, small bumps on nerve cells where connections form, in 5xFAD-M mice. In the computer modeling, the peptides' lowest-energy complexes with DNA settled on similar DNA sequences. EDR had predicted binding sites near genes linked to Alzheimer's disease, including APOE, CASP3 and SOD2.

What it doesn’t show

This was work in mice and in computer models, not a result in people, and the neuroplasticity effect was only a trend. The gene binding sites were predicted by modeling for EDR, not measured for KED.

The paper

Khavinson et al. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. Pharmaceuticals (Basel). 2021.

The compound

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking vesugen? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo